Vistakon Investigational Multi-purpose Contact Lens Care Solution.
NCT ID: NCT01055457
Last Updated: 2018-06-19
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
315 participants
INTERVENTIONAL
2009-11-01
2010-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigational Multi-purpose Contact Lens Care Solution.
NCT01055613
Vistakon Investigational Contact Lenses Worn for Daily Wear
NCT00717249
Vistakon Investigational Lens Worn as a Single Use Daily Wear
NCT01031004
Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium
NCT00724269
Comparative Clinical Evaluation of Soft Toric Lens Designs
NCT01552876
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Multi-Purpose Solution
contact lens care solution
Vistakon Investigational Multi-Purpose Solution II
contact lens care solution
ReNu MultiPlus Multi-Purpose Solution
contact lens care solution
ReNu MultiPlus Multi-Purpose Solution
contact lens care solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vistakon Investigational Multi-Purpose Solution II
contact lens care solution
ReNu MultiPlus Multi-Purpose Solution
contact lens care solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* best corrected distance visual acuity must be 20/25 or better in each eye
* must be wearing their habitual lenses on a daily wear basis
* must be willing to refrain from swimming during the study
Exclusion Criteria
* any clinically significant ocular disease
* any ocular infection
* use of certain medications
* any grade 2 or greater slit lamp findings
* any know sensitivity to marketed contact lens care solutions
* currently pregnant or lactating
* monovision corrected
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Vision Care, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mission Viejo, California, United States
Orlando, Florida, United States
Tallahassee, Florida, United States
Bloomington, Illinois, United States
Pittsburg, Kansas, United States
Jamestown, New York, United States
Vestal, New York, United States
Athens, Ohio, United States
Moon Township, Pennsylvania, United States
State College, Pennsylvania, United States
Amarillo, Texas, United States
Katy, Texas, United States
Salt Lake City, Utah, United States
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-1650
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.